11/20
03:11 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/12
02:00 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/4
02:09 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/27
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/19
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/18
08:30 am
ogen
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
Medium
Report
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
10/11
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/9
07:30 am
ogen
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
Low
Report
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
10/8
08:47 am
ogen
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate [Yahoo! Finance]
High
Report
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate [Yahoo! Finance]
10/8
08:45 am
ogen
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
High
Report
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
10/3
02:05 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/25
02:04 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/7
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/5
04:30 pm
ogen
Oragenics, Inc. Announces Closing of Public Offering
Low
Report
Oragenics, Inc. Announces Closing of Public Offering
9/4
08:47 am
ogen
Oragenics, Inc. Announces Pricing of Public Offering [Yahoo! Finance]
Medium
Report
Oragenics, Inc. Announces Pricing of Public Offering [Yahoo! Finance]
9/4
08:42 am
ogen
Analysis-Recession fears trounce rate cut cheer in latest market selloff [Yahoo! Finance Canada]
Low
Report
Analysis-Recession fears trounce rate cut cheer in latest market selloff [Yahoo! Finance Canada]
9/4
08:36 am
ogen
Oragenics, Inc. Announces Pricing of Public Offering
Medium
Report
Oragenics, Inc. Announces Pricing of Public Offering
8/30
02:03 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.